1 Human Hepatitis B Immunoglobulin (HBIG) Market Overview 1.1 Product Overview and Scope of Human Hepatitis B Immunoglobulin (HBIG) 1.2 Human Hepatitis B Immunoglobulin (HBIG) Segment by Type 1.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin 1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin 1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin 1.3 Human Hepatitis B Immunoglobulin (HBIG) Segment by Application 1.3.1 Human Hepatitis B Immunoglobulin (HBIG) Sales Comparison by Application: 2020 VS 2026 1.3.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) 1.3.3 Unexpected Crowd of Hepatitis B Infection 1.3.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers 1.4 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Estimates and Forecasts 1.4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue 2015-2026 1.4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales 2015-2026 1.4.3 Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region: 2020 Versus 2026 1.5 Human Hepatitis B Immunoglobulin (HBIG) Industry 1.6 Human Hepatitis B Immunoglobulin (HBIG) Market Trends 2 Global Human Hepatitis B Immunoglobulin (HBIG) Market Competition by Manufacturers 2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Manufacturers (2015-2020) 2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Manufacturers (2015-2020) 2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Human Hepatitis B Immunoglobulin (HBIG) Manufacturing Sites, Area Served, Product Type 2.5 Human Hepatitis B Immunoglobulin (HBIG) Market Competitive Situation and Trends 2.5.1 Human Hepatitis B Immunoglobulin (HBIG) Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Human Hepatitis B Immunoglobulin (HBIG) Players (Opinion Leaders) 3 Human Hepatitis B Immunoglobulin (HBIG) Retrospective Market Scenario by Region 3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Human Hepatitis B Immunoglobulin (HBIG) Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country 3.3.1 North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.3.2 North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country 3.4.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.4.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Region 3.5.1 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region 3.5.2 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country 3.6.1 Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.6.2 Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures by Country 3.7.1 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.7.2 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Human Hepatitis B Immunoglobulin (HBIG) Historic Market Analysis by Type 4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020) 4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2015-2020) 4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price Market Share by Type (2015-2020) 4.4 Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Human Hepatitis B Immunoglobulin (HBIG) Historic Market Analysis by Application 5.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020) 5.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2015-2020) 5.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2015-2020) 6 Company Profiles and Key Figures in Human Hepatitis B Immunoglobulin (HBIG) Business 6.1 Baxter 6.1.1 Corporation Information 6.1.2 Baxter Description, Business Overview and Total Revenue 6.1.3 Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Baxter Products Offered 6.1.5 Baxter Recent Development 6.2 CSL 6.2.1 CSL Corporation Information 6.2.2 CSL Description, Business Overview and Total Revenue 6.2.3 CSL Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.2.4 CSL Products Offered 6.2.5 CSL Recent Development 6.3 Bayer 6.3.1 Bayer Corporation Information 6.3.2 Bayer Description, Business Overview and Total Revenue 6.3.3 Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Bayer Products Offered 6.3.5 Bayer Recent Development 6.4 Grifols 6.4.1 Grifols Corporation Information 6.4.2 Grifols Description, Business Overview and Total Revenue 6.4.3 Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Grifols Products Offered 6.4.5 Grifols Recent Development 6.5 Octapharma 6.5.1 Octapharma Corporation Information 6.5.2 Octapharma Description, Business Overview and Total Revenue 6.5.3 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Octapharma Products Offered 6.5.5 Octapharma Recent Development 6.6 Shanghai RAAS 6.6.1 Shanghai RAAS Corporation Information 6.6.2 Shanghai RAAS Description, Business Overview and Total Revenue 6.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Shanghai RAAS Products Offered 6.6.5 Shanghai RAAS Recent Development 6.7 Hualan Biological 6.6.1 Hualan Biological Corporation Information 6.6.2 Hualan Biological Description, Business Overview and Total Revenue 6.6.3 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Hualan Biological Products Offered 6.7.5 Hualan Biological Recent Development 6.8 China Biologic 6.8.1 China Biologic Corporation Information 6.8.2 China Biologic Description, Business Overview and Total Revenue 6.8.3 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.8.4 China Biologic Products Offered 6.8.5 China Biologic Recent Development 6.9 Tiantan Biologic 6.9.1 Tiantan Biologic Corporation Information 6.9.2 Tiantan Biologic Description, Business Overview and Total Revenue 6.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Tiantan Biologic Products Offered 6.9.5 Tiantan Biologic Recent Development 6.10 Shuanglin Bio-pharmacy 6.10.1 Shuanglin Bio-pharmacy Corporation Information 6.10.2 Shuanglin Bio-pharmacy Description, Business Overview and Total Revenue 6.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Shuanglin Bio-pharmacy Products Offered 6.10.5 Shuanglin Bio-pharmacy Recent Development 6.11 Sichuan Yuanda Shuyang 6.11.1 Sichuan Yuanda Shuyang Corporation Information 6.11.2 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Description, Business Overview and Total Revenue 6.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Sichuan Yuanda Shuyang Products Offered 6.11.5 Sichuan Yuanda Shuyang Recent Development 6.12 Boya Bio-pharmaceutical 6.12.1 Boya Bio-pharmaceutical Corporation Information 6.12.2 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Description, Business Overview and Total Revenue 6.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Boya Bio-pharmaceutical Products Offered 6.12.5 Boya Bio-pharmaceutical Recent Development 6.13 Shanghai Institute of Biological 6.13.1 Shanghai Institute of Biological Corporation Information 6.13.2 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Description, Business Overview and Total Revenue 6.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Shanghai Institute of Biological Products Offered 6.13.5 Shanghai Institute of Biological Recent Development 7 Human Hepatitis B Immunoglobulin (HBIG) Manufacturing Cost Analysis 7.1 Human Hepatitis B Immunoglobulin (HBIG) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (HBIG) 7.4 Human Hepatitis B Immunoglobulin (HBIG) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Human Hepatitis B Immunoglobulin (HBIG) Distributors List 8.3 Human Hepatitis B Immunoglobulin (HBIG) Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Human Hepatitis B Immunoglobulin (HBIG) by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Human Hepatitis B Immunoglobulin (HBIG) by Type (2021-2026) 10.2 Human Hepatitis B Immunoglobulin (HBIG) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Human Hepatitis B Immunoglobulin (HBIG) by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Human Hepatitis B Immunoglobulin (HBIG) by Application (2021-2026) 10.3 Human Hepatitis B Immunoglobulin (HBIG) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Human Hepatitis B Immunoglobulin (HBIG) by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Human Hepatitis B Immunoglobulin (HBIG) by Region (2021-2026) 10.4 North America Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2021-2026) 10.5 Europe Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2021-2026) 10.6 Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2021-2026) 10.7 Latin America Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2021-2026) 10.8 Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Human Hepatitis B Immunoglobulin (HBIG) Manufacturers Covered in This Study Table 5. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Manufacturers (2015-2020) Table 7. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Human Hepatitis B Immunoglobulin (HBIG) Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Human Hepatitis B Immunoglobulin (HBIG) Sales Sites and Area Served Table 11. Manufacturers Human Hepatitis B Immunoglobulin (HBIG) Product Types Table 12. Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Human Hepatitis B Immunoglobulin (HBIG) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hepatitis B Immunoglobulin (HBIG) as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Human Hepatitis B Immunoglobulin (HBIG) Players Table 16. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Region (2015-2020) Table 17. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2015-2020) Table 18. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) by Region (2015-2020) Table 19. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2015-2020) Table 20. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2015-2020) (K Units) Table 21. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2015-2020) Table 22. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2015-2020) (US$ Million) Table 23. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2015-2020) Table 24. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2015-2020) (K Units) Table 25. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2015-2020) Table 26. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2015-2020) Table 32. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2015-2020) (K Units) Table 33. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2015-2020) Table 34. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country (2015-2020) Table 40. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020) Table 41. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2015-2020) Table 42. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) by Type (2015-2020) Table 43. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2015-2020) Table 44. Global Human Hepatitis B Immunoglobulin (HBIG) Price (USD/Unit) by Type (2015-2020) Table 45. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2015-2020) Table 46. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020) Table 47. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate by Application (2015-2020) Table 48. Baxter Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 49. Baxter Description and Business Overview Table 50. Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Baxter Main Product Table 52. Baxter Recent Development Table 53. CSL Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 54. CSL Corporation Information Table 55. CSL Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. CSL Main Product Table 57. CSL Recent Development Table 58. Bayer Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 59. Bayer Corporation Information Table 60. Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Bayer Main Product Table 62. Bayer Recent Development Table 63. Grifols Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 64. Grifols Corporation Information Table 65. Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Grifols Main Product Table 67. Grifols Recent Development Table 68. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 69. Octapharma Corporation Information Table 70. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Octapharma Main Product Table 72. Octapharma Recent Development Table 73. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 74. Shanghai RAAS Corporation Information Table 75. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Shanghai RAAS Main Product Table 77. Shanghai RAAS Recent Development Table 78. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 79. Hualan Biological Corporation Information Table 80. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Hualan Biological Main Product Table 82. Hualan Biological Recent Development Table 83. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 84. China Biologic Corporation Information Table 85. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. China Biologic Main Product Table 87. China Biologic Recent Development Table 88. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 89. Tiantan Biologic Corporation Information Table 90. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Tiantan Biologic Main Product Table 92. Tiantan Biologic Recent Development Table 93. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 94. Shuanglin Bio-pharmacy Corporation Information Table 95. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Shuanglin Bio-pharmacy Main Product Table 97. Shuanglin Bio-pharmacy Recent Development Table 98. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 99. Sichuan Yuanda Shuyang Corporation Information Table 100. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. Sichuan Yuanda Shuyang Main Product Table 102. Sichuan Yuanda Shuyang Recent Development Table 103. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 104. Boya Bio-pharmaceutical Corporation Information Table 105. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Boya Bio-pharmaceutical Main Product Table 107. Boya Bio-pharmaceutical Recent Development Table 108. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Corporation Information Table 109. Shanghai Institute of Biological Corporation Information Table 110. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Shanghai Institute of Biological Main Product Table 112. Shanghai Institute of Biological Recent Development Table 113. Sales Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Human Hepatitis B Immunoglobulin (HBIG) Distributors List Table 116. Human Hepatitis B Immunoglobulin (HBIG) Customers List Table 117. Market Key Trends Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 119. Key Challenges Table 120. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Forecast by Type (2021-2026) Table 121. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share Forecast by Type (2021-2026) Table 122. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) Forecast by Type (2021-2026) Table 123. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 124. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Forecast by Application (2021-2026) Table 125. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) Forecast by Application (2021-2026) Table 126. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Forecast by Region (2021-2026) Table 127. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share Forecast by Region (2021-2026) Table 128. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Forecast by Region (2021-2026) (US$ Million) Table 129. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share Forecast by Region (2021-2026) Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Human Hepatitis B Immunoglobulin (HBIG) Figure 2. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type: 2020 VS 2026 Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin Product Picture Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin Product Picture Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin Product Picture Figure 6. Global Human Hepatitis B Immunoglobulin (HBIG) Consumption Market Share by Application: 2020 VS 2026 Figure 7. Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) Figure 8. Unexpected Crowd of Hepatitis B Infection Figure 9. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Figure 10. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size 2015-2026 (US$ Million) Figure 11. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Capacity (K Units) (2015-2026) Figure 12. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Manufacturers in 2020 Figure 14. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Hepatitis B Immunoglobulin (HBIG) Revenue in 2019 Figure 16. Human Hepatitis B Immunoglobulin (HBIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2015-2020) Figure 18. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region in 2019 Figure 19. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2015-2020) Figure 20. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region in 2019 Figure 21. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country in 2019 Figure 22. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country in 2019 Figure 23. U.S. Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 24. U.S. Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 26. Canada Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country in 2019 Figure 28. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country in 2019 Figure 29. Germany Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 30. Germany Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 32. France Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 34. U.K. Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 36. Italy Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 38. Russia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region in 2019 Figure 40. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region in 2019 Figure 41. China Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 42. China Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 44. Japan Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 46. South Korea Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 48. India Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 50. Australia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 52. Taiwan Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 54. Indonesia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 56. Thailand Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 58. Malaysia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 60. Philippines Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 62. Vietnam Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country in 2019 Figure 64. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country in 2019 Figure 65. Mexico Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 66. Mexico Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 68. Brazil Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 70. Argentina Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Country in 2019 Figure 73. Turkey Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 74. Turkey Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 76. Saudi Arabia Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2020) (K Units) Figure 78. U.A.E Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Type (2015-2020) Figure 80. Sales Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Type in 2019 Figure 81. Revenue Share of Human Hepatitis B Immunoglobulin (HBIG) by Type (2015-2020) Figure 82. Revenue Market Share of Human Hepatitis B Immunoglobulin (HBIG) by Type in 2019 Figure 83. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Growth by Type (2015-2020) (K Units) Figure 84. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020) Figure 85. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Human Hepatitis B Immunoglobulin (HBIG) by Application (2015-2020) Figure 87. Global Revenue Share of Human Hepatitis B Immunoglobulin (HBIG) by Application in 2020 Figure 88. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Hualan Biological Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. China Biologic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Tiantan Biologic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Shuanglin Bio-pharmacy Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Boya Bio-pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Shanghai Institute of Biological Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Price Trend of Key Raw Materials Figure 102. Manufacturing Cost Structure of Human Hepatitis B Immunoglobulin (HBIG) Figure 103. Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (HBIG) Figure 104. Human Hepatitis B Immunoglobulin (HBIG) Industrial Chain Analysis Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Porter's Five Forces Analysis Figure 108. North America Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 109. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 111. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 113. Latin America Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 115. Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 117. Asia Pacific Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Bottom-up and Top-down Approaches for This Report Figure 119. Data Triangulation Figure 120. Key Executives Interviewed

Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical Shanghai Institute of Biological